Tenaya Therapeutics, Inc. financial data

Symbol
TNYA on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
171 Oyster Point Blvd., Suite 500, South San Francisco, CA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Nov 6, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 576 % -21.4%
Debt-to-equity 21.1 % +37.7%
Return On Equity -86.2 % -37.3%
Return On Assets -71.1 % -30.7%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 79.2M shares +16.3%
Common Stock, Shares, Outstanding 68.3M shares +2.2%
Entity Public Float 272M USD +73.5%
Common Stock, Value, Issued 8K USD +14.3%
Weighted Average Number of Shares Outstanding, Basic 86.2M shares +16.6%
Weighted Average Number of Shares Outstanding, Diluted 86.2M shares +16.6%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 90.9M USD -9.91%
General and Administrative Expense 31.8M USD -4.65%
Operating Income (Loss) -123M USD +8.6%
Nonoperating Income (Expense) 5.51M USD -16.9%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -117M USD +8.18%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -117M USD +8.18%
Earnings Per Share, Basic -1.45 USD/shares +21.6%
Earnings Per Share, Diluted -1.45 USD/shares +21.6%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 8.23M USD -90%
Marketable Securities, Current 115M USD -29.6%
Cash, Cash Equivalents, and Short-term Investments 79.5M USD -37.9%
Other Assets, Current 1.4M USD
Assets, Current 85.3M USD -32.7%
Property, Plant and Equipment, Net 37.8M USD -16.3%
Operating Lease, Right-of-Use Asset 12.6M USD +35.2%
Other Assets, Noncurrent 4.87M USD -15%
Assets 141M USD -27.3%
Accounts Payable, Current 5.84M USD -1.07%
Accrued Liabilities, Current 7.33M USD -29%
Liabilities, Current 16.2M USD -16.5%
Operating Lease, Liability, Noncurrent 11.5M USD +29.7%
Other Liabilities, Noncurrent 276K USD +12.2%
Liabilities 28M USD -1.87%
Accumulated Other Comprehensive Income (Loss), Net of Tax 76K USD
Retained Earnings (Accumulated Deficit) -491M USD -31.4%
Stockholders' Equity Attributable to Parent 113M USD -31.7%
Liabilities and Equity 141M USD -27.3%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -28.7M USD +5.38%
Net Cash Provided by (Used in) Financing Activities 46.8M USD
Net Cash Provided by (Used in) Investing Activities -4.49M USD -156%
Common Stock, Shares Authorized 1B shares 0%
Common Stock, Shares, Issued 68.3M shares +2.2%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 13.6M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 8.65M USD -89.6%
Deferred Tax Assets, Valuation Allowance 101M USD +42.4%
Deferred Tax Assets, Gross 104M USD +41.3%
Operating Lease, Liability 14.5M USD +20.7%
Payments to Acquire Property, Plant, and Equipment 564K USD -10.3%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -117M USD +8.08%
Lessee, Operating Lease, Liability, to be Paid 18.2M USD +14.8%
Property, Plant and Equipment, Gross 68.4M USD +1.67%
Operating Lease, Liability, Current 3.01M USD -4.53%
Lessee, Operating Lease, Liability, to be Paid, Year Two 3.86M USD +58%
Lessee, Operating Lease, Liability, to be Paid, Year One 3.86M USD -1.25%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure -10.4%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 3.68M USD -3.87%
Lessee, Operating Lease, Liability, to be Paid, Year Three 3.78M USD +172%
Deferred Tax Assets, Operating Loss Carryforwards 52.8M USD +27.9%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 200M shares 0%
Unrecognized Tax Benefits 4.52M USD +43.9%
Lessee, Operating Lease, Liability, to be Paid, Year Four 1.47M USD +3.01%
Operating Lease, Payments 1.33M USD +1.29%
Additional Paid in Capital 603M USD +12%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 2.16M USD +1.17%
Deferred Tax Assets, Net of Valuation Allowance 3.04M USD +12.8%
Share-based Payment Arrangement, Expense 16.7M USD +14.7%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%